Multiple Primary Malignant Neoplasms in African Americans: A Case Series and Literature Review.

african americans colorectal cancer diagnosis of multiple myeloma hepatocellular carcinoma (hcc) multiple primary cancer multiple primary malignant neoplasm multiple primary neoplasms non-small-cell lung carcinoma (nsclc)

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jan 2022
Historique:
accepted: 25 01 2022
entrez: 1 3 2022
pubmed: 2 3 2022
medline: 2 3 2022
Statut: epublish

Résumé

Multiple primary malignant neoplasms (MPMNs) or multiple primary malignancies are defined as two or more histologically distinct malignancies present in the same individual. While second or higher-order malignancies account for approximately 18% of all cancers in the United States, it is reasonable to presume that MPMNs are now occurring more frequently than previously reported. Underserved groups such as blacks and Hispanics may represent a high proportion of these underreported cases due to well-established health disparities. Although the role of health disparities has been well established in single primary malignancies, less is known on racial differences in patients with multiple primaries. In comparing MPMNs by race, blacks have lower survival rates compared to white patients. Moreover, despite the lower overall incidence of MPMNs in blacks compared to white patients, when broken down by the specific types of cancers and gender, there are significant racial disparities in the incidence of prostate cancer and possibly other cancers. Further research and case reports are required to explore the risk factors of developing MPMNs in these groups. Our case series explores three African American patients with MPMNs that are rarely described in the literature and outlines the management challenges of treating multiple malignancies.

Identifiants

pubmed: 35228943
doi: 10.7759/cureus.21585
pmc: PMC8867714
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e21585

Informations de copyright

Copyright © 2022, Sidhom et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cureus. 2021 Dec 5;13(12):e20185
pubmed: 35004008
Aust Prescr. 2020 Jun;43(3):94-95
pubmed: 32675911
Expert Rev Anticancer Ther. 2018 Dec;18(12):1169-1175
pubmed: 30304963
Int J Surg Case Rep. 2013;4(5):493-5
pubmed: 23562900
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
ESMO Open. 2017 May 2;2(2):e000172
pubmed: 28761745

Auteurs

Fady Sidhom (F)

Internal Medicine, Howard University Hospital, Washington, DC, USA.

Devon Jackson (D)

Pathology, Howard University Hospital, Washington, DC, USA.

Ahmed Ali (A)

Medical Oncology, Howard University Hospital, Washington, DC, USA.

Babak Shokrani (B)

Pathology, Howard University Hospital, Washington, DC, USA.

Lekidelu Taddesse-Heath (L)

Pathology, Howard University Hospital, Washington, DC, USA.

Classifications MeSH